APOGLYX
Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients.
APOGLYX
Social Links:
Industry:
Biotechnology
Founded:
2015-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.apoglyx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
6 M SEK
Technology used in webpage:
Euro Team.blue
Similar Organizations
Algonist Biotechnologies
Algonist Biotechnologies is a pre-clinical stage biotechnology company, developing novel small molecule therapeutics for chronic pain.
aratinga.bio
aratinga.bio is a preclinical-stage biotech company developing novel immunotherapies to treat cancer.
Investors List
Almi Invest
Almi Invest investment in Venture Round - Apoglyx
LU Innovation
LU Innovation investment in Venture Round - Apoglyx
Official Site Inspections
http://www.apoglyx.com
- Host name: linux299.unoeuro.com
- IP address: 93.191.156.189
- Location: Langeskov Denmark
- Latitude: 55.3565
- Longitude: 10.5845
- Timezone: Europe/Copenhagen
- Postal: 5550
More informations about "Apoglyx"
Apoglyx - Apoglyx
ApoGlyx develops first-in-class therapies based on aquaporin inhibitors. Aquaporins are protein channels with broad importance in health and disease, ranging from maintaining the body’s …See details»
Apoglyx - Crunchbase Company Profile & Funding
Organization. Apoglyx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Apoglyx is a pre-clinical stage virtual biotech …See details»
ApoGlyx Company Profile 2024: Valuation, Funding & Investors
ApoGlyx General Information Description. Developer of therapeutic concepts designed for metabolical and inflammatory diseases treatment of sepsis. The company specializes in …See details»
ApoGlyx Overview | SignalHire Company Profile
Apoglyx is a pre-clinical stage biotech company with the aim to develop a small molecule therapy for sepsis, and further indications, based on inhibition of Aquaporin-9. ... Organization …See details»
ApoGlyx AB Company Profile | Lund, Skåne, Sweden | Competitors ...
Find company research, competitor information, contact details & financial data for ApoGlyx AB of Lund, Skåne. Get the latest business insights from Dun & Bradstreet.See details»
Apoglyx - Funding, Financials, Valuation & Investors - Crunchbase
Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients. Search Crunchbase. ... How much funding has this organization …See details»
ApoGlyx AB - Drug pipelines, Patents, Clinical trials - Synapse
Explore ApoGlyx AB with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Infectious Diseases, Technology Platform:Small molecule drug, Drug:RG-100204. ...See details»
Apoglyx Company Profile - Office Locations, Competitors ... - Craft
Apoglyx is a biotech company developing a small molecule oral therapy for type 2 diabetes patients. It focuses on the preclinical development and the commercialization of its patented …See details»
Apoglyx - Products, Competitors, Financials, Employees, …
Apoglyx is a biotechnology company focused on developing first-in-class therapies for inflammatory diseases. Their main offerings include small molecule therapies that target …See details»
Apoglyx – SmiLe Incubator
The company is based on the fundamental discovery of aquaporins by Nobel Laureate professor Peter Agre, Johns Hopkins University Medical School, and the extensive, collaborative …See details»
ApoGlyx | LU Innovation
Dec 21, 2020 ApoGlyx The American Peter Agre won the Nobel Prize in 2003 for the discovery of aquaporins. Aquaporins are channels for water to enter and leave cells, with broad …See details»
Apoglyx – NOME
Apoglyx joined NOME in 2021 and is based in Lund. The company is lead by Michael Rützler who is also co-founder of the Apoglyx. Company details. Website. Apoglyx.com. More companies. …See details»
ApoGlyx - Overview, News & Similar companies | ZoomInfo.com
View ApoGlyx (www.apoglyx.com) location in Skane, Sweden , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
CONTACT - Apoglyx
ApoGlyx is located in Lund, within the Medicon Valley region, one of the best life science environments in Europe. In this area around the Öresund between Sweden and Denmark, …See details»
ApoGlyx develops innovative drugs at SmiLe and raises €0.6 million
Oct 25, 2021 The new SmiLe company ApoGlyx has raised €0.6 million in a rights issue, with Almi Invest providing half of the funding and the rest coming from private investors. ... as well …See details»
ApoGlyx Company Information - Funding, Investors, and More
The company ApoGlyx has raised a total of $700k in funding over 1 rounds. Key Insights: Unknown: $700k; 2021. ApoGlyx Unknown (2021, $0M) $700k. Discover ApoGlyx. Company …See details»
Apoglyx - MVA
Apoglyx exists to bring innovative therapies to patients. Our most advanced approach is targeting systemic inflammatory diseases like acute pancreatitis, COVID-19 and sepsis, where an …See details»
R&D Portfolio - Apoglyx
The ApoGlyx lead compound RG100204 has demonstrated remarkably robust effects, protecting from organ damage in a clinically relevant in vivo model of bacterial infection, systemic …See details»
Amylyx Pharmaceuticals Appoints Dan Monahan as Chief …
3 days ago CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the appointment of Dan Monahan as …See details»
NEWS - Apoglyx
ApoGlyx is happy to announce that we have just closed a 6 million Swedish kronor investment round, coming from Almi Invest as well as from Swedish and Danish private investors. This …See details»